alliin has been researched along with eicosapentaenoic acid in 1 studies
| Studies (alliin) | Trials (alliin) | Recent Studies (post-2010) (alliin) | Studies (eicosapentaenoic acid) | Trials (eicosapentaenoic acid) | Recent Studies (post-2010) (eicosapentaenoic acid) |
|---|---|---|---|---|---|
| 149 | 4 | 71 | 7,171 | 1,304 | 3,623 |
| Protein | Taxonomy | alliin (IC50) | eicosapentaenoic acid (IC50) |
|---|---|---|---|
| Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | Homo sapiens (human) | 4 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 7.1 | |
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Camfield, D; Kean, JD; Kras, M; Sarris, J; Scholey, A; Silberstein, R; Stough, C | 1 |
1 trial(s) available for alliin and eicosapentaenoic acid
| Article | Year |
|---|---|
A randomized controlled trial investigating the effects of PCSO-524, a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) exp
Topics: Adolescent; Adolescent Behavior; Affect; Animals; Attention Deficit Disorder with Hyperactivity; Child; Child Behavior; Cognition; Cysteine; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Fatty Acids, Nonesterified; Fatty Acids, Omega-3; Female; Humans; Lipids; Male; New Zealand; Perna; Treatment Outcome | 2013 |